Literature DB >> 23784676

Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery.

Yuji Takakura1, Takao Hinoi, Hiroyuki Egi, Manabu Shimomura, Tomohiro Adachi, Yasufumi Saito, Naoki Tanimine, Masashi Miguchi, Hideki Ohdan.   

Abstract

PURPOSE: Surgical site infection (SSI) is a frequent complication of elective surgery for colorectal cancer. The classical clinical markers of infection-elevations in white blood cell count, C-reactive protein (CRP) level, and body temperature-do not precisely predict SSI after elective colorectal resection. The objective of this study was to evaluate the efficacy of procalcitonin (PCT) as a tool for diagnosis of SSI in elective surgery for colorectal cancer.
METHODS: A total of 114 consecutive patients undergoing elective colorectal resection for cancer were evaluated. Routine blood samples, for determining PCT level, CRP plasma concentration, and white blood cell count, were obtained on postoperative days (POD) 1 and 3. Predictive values for each of the laboratory markers were examined.
RESULTS: SSI was diagnosed in 18 (15.7 %) of 114 patients. Patients with SSI exhibited significantly higher PCT levels (on PODs 1 and 3) and CRP levels (on POD 3) than did patients without SSI. According to receiver operating characteristic analysis, PCT showed the highest area under the curve (AUC) for predicting SSI on both PODs 1 and 3 (AUC, 0.76 and 0.77, respectively). Multivariate logistic regression analysis showed that PCT (on PODs 1 and 3) was an independent predictor for SSI (odds ratio = 14.41 and 9.79, respectively).
CONCLUSION: Serum PCT is more reliable laboratory marker for the early diagnosis of SSI after elective colorectal cancer surgery, compared with conventional inflammatory indicators. PCT could serve as an additional diagnostic tool for the early identification of SSI to improve clinical decision making.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784676     DOI: 10.1007/s00423-013-1095-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  22 in total

1.  Predictive value of procalcitonin for the diagnosis of bowel strangulation.

Authors:  B Papaziogas; G Anthimidis; I Koutelidakis; S Atmatzidis; K Atmatzidis
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

2.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

3.  Predictive value of procalcitonin for the diagnosis of bowel strangulation.

Authors:  Refik Ayten; Osman Dogru; Cemalettin Camci; Erhan Aygen; Ziya Cetinkaya; Handan Akbulut
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 4.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Authors:  Philipp Schuetz; Beat Müller; Mirjam Christ-Crain; Daiana Stolz; Michael Tamm; Lila Bouadma; Charles E Luyt; Michel Wolff; Jean Chastre; Florence Tubach; Kristina B Kristoffersen; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Long Wei; Neera Bhatnagar; Heiner C Bucher; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

5.  Procalcitonin in the setting of complicated postoperative course after liver transplantation.

Authors:  A Perrakis; S Yedibela; V Schellerer; W Hohenberger; V Müller
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

6.  Procalcitonin as an early predictor of postoperative infectious complications in patients with acute traumatic spinal cord injury.

Authors:  H Nie; D Jiang; Y Ou; Z Quan; J Hao; C Bai; X Huang; H An
Journal:  Spinal Cord       Date:  2011-01-18       Impact factor: 2.772

7.  Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.

Authors:  Bettina M Rau; Esko A Kemppainen; Andrew A Gumbs; Markus W Büchler; Karl Wegscheider; Claudio Bassi; Pauli A Puolakkainen; Hans G Beger
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Comparison of procalcitonin and CrP in the postoperative course after lung decortication.

Authors:  Giovanni L Carboni; Rene Fahrner; Amiq Gazdhar; Gert Printzen; Ralph Alexander Schmid; Beatrix Hoksch
Journal:  Eur J Cardiothorac Surg       Date:  2008-05       Impact factor: 4.191

9.  The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery.

Authors:  Sabina Hunziker; Thomas Hügle; Katrin Schuchardt; Isabelle Groeschl; Philipp Schuetz; Beat Mueller; Walter Dick; Urs Eriksson; Andrej Trampuz
Journal:  J Bone Joint Surg Am       Date:  2010-01       Impact factor: 5.284

10.  Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.

Authors:  Gian Paolo Castelli; Claudio Pognani; Michael Meisner; Antonio Stuani; Daniela Bellomi; Laura Sgarbi
Journal:  Crit Care       Date:  2004-06-10       Impact factor: 9.097

View more
  23 in total

1.  Monitoring c-reactive protein after laparoscopic colorectal surgery excludes infectious complications and allows for safe and early discharge.

Authors:  Michel Adamina; Rene Warschkow; Franziska Näf; Bianka Hummel; Thomas Rduch; Jochen Lange; Thomas Steffen
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

Review 2.  Systematic review and meta-analysis of the use of serum procalcitonin levels to predict intra-abdominal infections after colorectal surgery.

Authors:  Winson Jianhong Tan; Wan Qi Ng; Rehena Sultana; Nurun Nisa de Souza; Min Hoe Chew; Fung Joon Foo; Choong Leong Tang; Wah Siew Tan
Journal:  Int J Colorectal Dis       Date:  2018-01-05       Impact factor: 2.571

Review 3.  [Perioperative complications of the lower gastrointestinal tract : Prevention, recognition and treatment].

Authors:  Y Kulu; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2015-04       Impact factor: 0.955

4.  Inflammatory markers as predictors of surgical site infection after elective colorectal surgery: authors' reply.

Authors:  Yuji Takakura; Hideki Ohdan
Journal:  Langenbecks Arch Surg       Date:  2014-05-10       Impact factor: 3.445

5.  Inflammatory markers as predictors of surgical site infection after elective colorectal cancer surgery.

Authors:  Pablo Ortega-Deballon; Nicolas Lagoutte; Olivier Facy
Journal:  Langenbecks Arch Surg       Date:  2014-05-14       Impact factor: 3.445

6.  Procalcitonin and C-reactive protein as early markers of postoperative intra-abdominal infection in patients operated on colorectal cancer.

Authors:  E Domínguez-Comesaña; S M Estevez-Fernández; V López-Gómez; J Ballinas-Miranda; R Domínguez-Fernández
Journal:  Int J Colorectal Dis       Date:  2017-09-16       Impact factor: 2.571

7.  Procalcitonin and C-reactive protein as early markers of anastomotic leak after laparoscopic colorectal surgery within an enhanced recovery after surgery (ERAS) program.

Authors:  José Luis Muñoz; María Oliva Alvarez; Vicent Cuquerella; Elena Miranda; Carlos Picó; Raquel Flores; Marta Resalt-Pereira; Pedro Moya; Ana Pérez; Antonio Arroyo
Journal:  Surg Endosc       Date:  2018-03-08       Impact factor: 4.584

Review 8.  Implications of preoperative hypoalbuminemia in colorectal surgery.

Authors:  Adam Truong; Mark H Hanna; Zhobin Moghadamyeghaneh; Michael J Stamos
Journal:  World J Gastrointest Surg       Date:  2016-05-27

Review 9.  Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review.

Authors:  Zainna C Meyer; Jennifer M J Schreinemakers; Ruud A L de Waal; Lijckle van der Laan
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

10.  Perioperative advantages of modified laparoscopic vs open splenectomy and azygoportal disconnection.

Authors:  Guo-Qing Jiang; Ping Chen; Jian-Jun Qian; Jie Yao; Xiao-Dong Wang; Sheng-Jie Jin; Dou-Sheng Bai
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.